Komipharm International Co., Ltd. (KOSDAQ:041960)
5,350.00
-300.00 (-5.31%)
Jun 27, 2025, 3:30 PM KST
Komipharm International Revenue
Komipharm International had revenue of 14.41B KRW in the quarter ending March 31, 2025, with 11.70% growth. This brings the company's revenue in the last twelve months to 60.29B, up 32.16% year-over-year. In the year 2024, Komipharm International had annual revenue of 58.78B with 37.83% growth.
Revenue (ttm)
60.29B
Revenue Growth
+32.16%
P/S Ratio
6.06
Revenue / Employee
374.46M
Employees
161
Market Cap
365.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 58.78B | 16.13B | 37.83% |
Dec 31, 2023 | 42.65B | 2.85B | 7.15% |
Dec 31, 2022 | 39.80B | 3.95B | 11.03% |
Dec 31, 2021 | 35.85B | -1.31B | -3.53% |
Dec 31, 2020 | 37.16B | 1.67B | 4.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 15.28T |
Doosan Enerbility | 15.88T |
Kia Corporation | 109.25T |